UBS Maintains Neutral on GE HealthCare Techs, Raises Price Target to $73

Benzinga · 2d ago
UBS analyst Graham Doyle maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and raises the price target from $67 to $73.